Navigation Links
Head Lice Returns to School: Five Tips to Avoid Panic and Worry
Date:8/4/2011

FLORHAM PARK, N.J., Aug. 4, 2011 /PRNewswire/ -- It's back-to-school season and for many families, that means new morning routines, homework and head lice.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/shionogi/50422/

(Photo: http://photos.prnewswire.com/prnh/20110804/MM45457 )

Each year, approximately 6 to 12 million children in the U.S. are infested with this common, six-legged critter that feeds on human blood. After weeks at summer camps, sleepovers and sharing of personal items, back-to-school season usually is the time when head lice infestation is noticed.

"Unfortunately, panic and worry are common reactions when parents discover head lice," according to Adelaide Hebert, M.D., Houston, Texas.

"Out of concern and need to get rid of the infestation quickly, many parents may turn to unproven home remedies or homeopathic products," added Dr. Hebert. "Unfortunately, these home remedies have never been studied, tested, or proven to be safe on children. There also has been resistance reported with some head lice treatment products, which may lead to ineffective treatment."

Dr. Hebert offers parents five tips during head lice season:

  1. Parents shouldn't panic. In many cases, what parents see on the child's head may not be head lice.
  2. If parents or school nurse suspect head lice, a visit or call to the child's doctor can confirm the diagnosis.
  3. Parents should use only products that are recommended by a doctor to treat head lice.
  4. It's important for parents to carefully follow the doctor's instructions to make sure the treatment was properly applied.
  5. Because every school policy on head lice differs, it's important for parents to talk with the school nurse. Healthcare professionals recommend that children remain in school since head lice do not transmit disease and are treatable.

For more information about head lice, parents can visit the following websites:


About Shionogi Inc.

Shionogi Inc. is the U.S. affiliate of Shionogi & Co., Ltd., a major research-driven pharmaceutical company, headquartered in Osaka Japan, dedicated to placing the highest value on patients. Shionogi's Research and Development currently targets three therapeutic areas: Infectious Diseases, Pain, and Metabolic Syndrome. In addition, Shionogi is engaged in new research areas such as allergy and cancer. Contributing to the health of patients around the world through development in these therapeutic areas is Shionogi's primary goal. For more information on Shionogi Inc., headquartered in Florham Park, NJ, please visit www.shionogi.com.


'/>"/>
SOURCE Shionogi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ODT Forum Returns to Memphis with Unique Opportunity for Orthopedic Manufacturers
2. Today® Sponge Returns to Store Shelves in Canada
3. Jury Returns Verdict in VNUS Patent Infringement Lawsuit With Total Vein Systems and biolitec Finding Some Patent Claims Invalid and Some Infringed
4. Blood Donors Needed as School, Fall Season Returns
5. 2nd Annual Orthopedic Design & Technology Forum Returns April 28 to the FedEx Institute of Technology, University of Memphis
6. Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions
7. Molecular Devices Returns to Life Sciences Marketplace
8. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
9. Drugstore Lobby Looks for Free Pass to Avoid Fraud, Waste, and Abuse Detection
10. Avoid Illness Through Easy Daily Check
11. Michael Jacksons Death Could Have Been Avoided With a Brain Monitor Says Anesthesiologist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
(Date:2/27/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... M.D., Ph.D., as President and Chief Executive Officer (CEO) and ... Dr. Craig succeeds Richard Love , interim President and ... of Directors.  Dr. Craig has over 20 years of experience ... and Europe . "On behalf ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , The New Jersey ... as well as advocacy for the state and region‘s technology businesses, hosted their ... The Council's Innovation Forecast event highlights innovation throughout the region from small to ...
Breaking Medicine News(10 mins):